MedPath

广东先强药业有限公司

Ownership
-
Established
2002-09-23
Employees
-
Market Cap
-
Website
https://www.xianqiang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Sodium Gluconate

Product Name
葡萄糖酸钠
Approval Number
国药准字H20070277
Approval Date
Dec 24, 2024
NMPA

Trimetazidine Hydrochloride

Product Name
盐酸曲美他嗪
Approval Number
国药准字H20066771
Approval Date
Dec 24, 2024
NMPA

Vidarabine Monphosphate

Product Name
单磷酸阿糖腺苷
Approval Number
国药准字H20059894
Approval Date
Jan 12, 2021
NMPA

Ritodrine Hydrochloride

Product Name
盐酸利托君
Approval Number
国药准字H20070129
Approval Date
Dec 23, 2016
NMPA

Foscarnet Sodium

Product Name
膦甲酸钠
Approval Number
国药准字H20064445
Approval Date
Nov 7, 2016
NMPA

Methionine and Vitamin B1 for Injection

Product Name
注射用甲硫氨酸维B1
Approval Number
国药准字H20061010
Approval Date
Sep 10, 2015
NMPA

Enoxacin Gluconate for Injection

Product Name
注射用葡萄糖酸依诺沙星
Approval Number
国药准字H20051307
Approval Date
Aug 27, 2015
NMPA

Meclofenoxate Hydrochloride for Injection

Product Name
注射用盐酸甲氯芬酯
Approval Number
国药准字H20133168
Approval Date
Aug 27, 2015
NMPA

tiopronin

Product Name
硫普罗宁
Approval Number
国药准字H20055223
Approval Date
Aug 27, 2015
NMPA

Antiradon for Injection

Product Name
注射用乙胺硫脲
Approval Number
国药准字H20059452
Approval Date
Aug 27, 2015
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.